Ralf Bargou, MD
Medizinische Klinik und Poliklinik II, Würzburg
1
1
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Dario Campana
NUHS Singapore
Shared therapeutic areas:
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Li Li, MD
Kunming Hope of Health Hospital
Shared therapeutic areas:
Kevin Curran, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Franco Locatelli, MD, PhD
Director Department of Hematology/Oncology and Cell and Gene Therapy
Shared therapeutic areas:
Abdel-Azim Hisham, MD
Loma Linda University
Shared therapeutic areas:
Peihua Lu, MD/PHD
HeiBei YanDa Ludaopei hospital
Shared therapeutic areas:
David Shook, MD
Nkarta, Inc.
Shared therapeutic areas:
Jianxiang Wang, Dr.
Institute of Hematology & Blood Diseases Hospital, China
Shared therapeutic areas:
Troy Quigg, DO, MS
Helen DeVos Children's Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)
All 1 trials loaded